Management of Bleeding Liver Tumors
Overview
General Surgery
Authors
Affiliations
Liver tumors bleed rarely; management has changed radically during the last 20years, advancing from emergency surgery with poor results to multidisciplinary management. The first steps are the diagnosis and control of bleeding. Abdominopelvic CT scan should be performed as soon as patient hemodynamics allow. When active bleeding is visualized, arterial embolization, targeted as selectively as possible, is preferable to surgery, which should be reserved for severe hemodynamic instability or failure of interventional radiology. When surgery is unavoidable, abbreviated laparotomy (damage control) with perihepatic packing is recommended. The second step is determination of the etiology and treatment of the underlying tumor. Adenoma and hepatocellular carcinoma (HCC) are the two most frequently encountered tumors in this context. Liver MRI after control of the bleeding episode generally leads to the diagnosis although sometimes the analysis can be difficult because of the hematoma. Prompt resection is indicated for HCC, atypical adenoma or lesions at risk for degeneration to hepatocellular carcinoma. For adenoma with no suspicion of malignancy, it is best to wait for the hematoma to resorb completely before undertaking appropriate therapy.
Hemoperitoneum Secondary to Spontaneous Hepatic Artery Hemorrhage: A Case Report.
Mohmed M, Saber A, Iqbal S, Gul R, Yammahi A Cureus. 2025; 17(2):e78371.
PMID: 40041659 PMC: 11879628. DOI: 10.7759/cureus.78371.
Lopes S, Santos I, Teixeira M, Sequeira C, Carvalho A, Gamito E GE Port J Gastroenterol. 2024; 31(6):443-448.
PMID: 39633913 PMC: 11614446. DOI: 10.1159/000538340.
Thomasson J, Andersson B, Thompson L, Williamsson C J Med Case Rep. 2024; 18(1):462.
PMID: 39313807 PMC: 11421102. DOI: 10.1186/s13256-024-04797-5.
Bleeding hepatocellular adenoma: historical series and outcomes.
Cacciatori F, Rodrigues P, Fontes P Rev Col Bras Cir. 2023; 50:e20233549.
PMID: 37436285 PMC: 10508653. DOI: 10.1590/0100-6991e-20233549-en.
Pan T, Gao F, Huang X, Xu X Clin Transl Oncol. 2023; 26(1):155-170.
PMID: 37328589 DOI: 10.1007/s12094-023-03232-3.